1) procaspase-3
半胱天冬酶-3酶原
1.
The expression of procaspase-3 in hippocampus following transient forebrain ischemia was explored,and the possible relationship of ischemia/reperfusion and procaspase-3 activation was observed.
通过测定脑缺血再灌注时海马中半胱天冬酶-3酶原(procaspase-3)的表达变化,从细胞凋亡的角度探讨脑缺血再灌注损伤的分子生物学机制及procaspase-3的活化机制。
2) Caspase 3
半胱天冬酶3
1.
Effect of Three Traditional Chinese Medicine Compounds on Level of Expression of Caspase 3 of Spleen in Sepsis Rats;
3种中药对脓毒症大鼠脾脏半胱天冬酶3表达影响的对比研究
3) caspase-3
半胱天冬酶-3
1.
Expression of caspase-3 and Bcl-2 in lesional skin of patients with lichen planus;
半胱天冬酶-3、Bcl-2在扁平苔藓皮损中的表达
2.
OBJECTIVE To investigate the inhibiton of polypeptide from Chlamys farreri (PCF) on UVA-induced HaCaT cells apoptosis through p38 mitogen activated protein kinase (MAPK) pathway and caspase-3.
目的从p38促细胞分裂剂激活性蛋白激酶(p38MAPK)通路和半胱天冬酶-3(caspase-3)的角度,研究扇贝多肽(poly-peptidefromChlamysfarreri,PCF)抑制紫外线A波(UVA)引起的HaCaT细胞凋亡的分子机制。
3.
Objective To define the issue as to whether the expression of PCNA,Caspase-3 is correlated with the differentiation degree,clinical progression and metastasis of gastric cancer.
目的探讨增殖细胞核抗原(PCNA)、半胱天冬酶-3(Caspase-3)与胃癌组织分化程度、临床分期及浸润转移的关系,为临床早期诊断、治疗提供实验依据。
5) Caspase
半胱天冬酶
1.
Triptolide induces apoptosis in myelodysplastic syndromes MUTZ-1 cells through activation of caspases and down-regulation of IAPs;
雷公藤内酯醇下调凋亡抑制蛋白、活化半胱天冬酶诱导骨髓增生异常综合征细胞株细胞凋亡的研究
2.
Effect of Supplement Energy and Nourish Lung Herbs on Drug-Resistance Lung Cancer with Mechanisms of Mitochondrial and Caspase Signal;
益气养肺方干预肺癌化疗耐药的线粒体及半胱天冬酶机制
3.
Purpose: To study whether sesquiterpene lactones(SLs) have the inducible apoptosis effect on human nasopharyngeal carcinoma (NPC) and it s relation with the mechanism of caspase activation, Methods: NPC cell line (CNE1) was treated with parthenolide(PN),the principal active component of SLs.
目的 :探讨半胱天冬酶(caspase)活化途径是否在倍半萜烯内酯(SLs)诱导人鼻咽癌(NPC)细胞凋亡中起作用。
6) caspase-3
半胱天冬酶
1.
This study was purposed to observe the changes of caspase-3 activity during apoptosis of HL-60 cells induced by an iron chelator, DFO (deferoxamine), and to explore the mechanism underlying apoptosis in HL-60 cells.
为了研究铁螯合剂—去铁胺(deferoxamine,DFO)诱导人白血病细胞株HL-60凋亡时半胱天冬酶-3(caspase-3)活性的变化并探讨DFO诱导凋亡的可能机制。
2.
[Objective] This paper was conducted to analyze the activity of Caspase-3 and mRNA translation in the EGCG-induced apoptotic.
[目的]研究绿茶多酚(EGCG)诱导肝癌细胞Hep-G2凋亡过程中半胱天冬酶-3(Caspase-3)蛋白活性与mRNA的变化。
补充资料:半胱氨酸乙酯,半胱乙酯
药物名称:半胱氨酸乙酯
英文名:
别名: 半胱氨酸乙酯,半胱乙酯
适应症: 用于治疗急、慢性支气管炎、肺结核、咽喉炎等症以及手术后咳痰困难者。
用量用法: 口服:每次0.1g,每日3次。气管滴入:0.25g溶于5ml溶液内滴入或雾化吸入。
注意事项: 可有恶心、呕吐、食欲不振等;偶有失眠、头晕、皮疹或使哮喘患者产生支气管痉挛。故哮喘患者慎用;严重肝脏及心脏患者忌用。水溶液放置时能缓缓分解,故应临用前配制。
规格: 片剂:0.1g;粉剂:0.25g、0.5g。
类别:祛痰药
英文名:
别名: 半胱氨酸乙酯,半胱乙酯
适应症: 用于治疗急、慢性支气管炎、肺结核、咽喉炎等症以及手术后咳痰困难者。
用量用法: 口服:每次0.1g,每日3次。气管滴入:0.25g溶于5ml溶液内滴入或雾化吸入。
注意事项: 可有恶心、呕吐、食欲不振等;偶有失眠、头晕、皮疹或使哮喘患者产生支气管痉挛。故哮喘患者慎用;严重肝脏及心脏患者忌用。水溶液放置时能缓缓分解,故应临用前配制。
规格: 片剂:0.1g;粉剂:0.25g、0.5g。
类别:祛痰药
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条